We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+17.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$74.4M
AUM Growth
-$7.7M
Cap. Flow
-$18.1M
Cap. Flow %
-24.3%
Top 10 Hldgs %
31.3%
Holding
122
New
27
Increased
23
Reduced
27
Closed
36
Avg Time Held Equity + Options
2.7 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.5 quarters
Avg Time Held Equity only
2.8 quarters
Top 10 Avg Time Held Equity only
0.3 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$1.5M
2
NOW icon
ServiceNow
NOW
+$1.34M
3
DXC icon
DXC Technology
DXC
+$1.33M
4
MSFT icon
Microsoft
MSFT
+$1.31M
5
AMZN icon
Amazon
AMZN
+$1.27M

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$2.44M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.3M
3
BIIB icon
Biogen
BIIB
+$2.15M
4
WFT
Weatherford International plc
WFT
+$2.13M
5
CSC
Computer Sciences
CSC
+$2.05M

Sector Composition

Rank Sector Weight
1 Healthcare 52.74%
2 Technology 15.35%
3 Miscellaneous 14.63%
4 Consumer Discretionary 6.1%
5 Communication Services 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
$2.99M 4.02%
28,837
+15,324
+113% +$1.25M
2014 Q4
10 quarters
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.94M 3.94%
52,269
+16,907
+48% +$677K
2016 Q4
2 quarters
XLV icon
3
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$2.76M 3.71%
+34,800
New +$2.65M
2017 Q2
0 quarters
PBYI icon
4
Puma Biotechnology
PBYI
$522M
$2.56M 3.44%
29,282
+11,668
+66% +$653K
2016 Q4
2 quarters
ELV icon
5
Elevance Health
ELV
$92.2B
$2.36M 3.17%
12,534
+1,897
+18% +$341K
2016 Q4
2 quarters
BABA icon
6
Alibaba
BABA
$276B
$2.19M 2.94%
15,541
-1,426
-8% -$176K
2017 Q1
1 quarter
GDDY icon
7
GoDaddy
GDDY
$13B
$1.98M 2.65%
46,566
+9,279
+25% +$372K
2016 Q4
2 quarters
UHS icon
8
Universal Health Services
UHS
$10.6B
$1.84M 2.48%
15,117
+270
+2% +$32.1K
2017 Q1
1 quarter
QQQ icon
9
PUT
Invesco QQQ Trust
QQQ
$497B
$1.83M 2.46%
+13,300
New +$1.83M
2017 Q2
0 quarters
HUM icon
10
Humana
HUM
$50.5B
$1.83M 2.45%
7,591
-1,724
-19% -$390K
2016 Q3
3 quarters
MSFT icon
11
Microsoft
MSFT
$4.04T
$1.79M 2.41%
25,984
+19,067
+276% +$1.31M
2017 Q1
1 quarter
PCRX icon
12
Pacira BioSciences
PCRX
$1.45B
$1.72M 2.31%
36,119
+1,906
+6% +$88.4K
2016 Q4
2 quarters
AERI
13
DELISTED
Aerie Pharmaceuticals
AERI
$1.71M 2.29%
32,496
+5,207
+19% +$242K
2015 Q1
9 quarters
EW icon
14
Edwards Lifesciences
EW
$49.1B
$1.65M 2.21%
41,814
+8,769
+27% +$320K
2014 Q4
10 quarters
MCK icon
15
McKesson
MCK
$112B
$1.63M 2.19%
+9,888
New +$1.5M
2017 Q2
0 quarters
BAX icon
16
Baxter International
BAX
$12.9B
$1.62M 2.18%
26,755
-1,330
-5% -$75.5K
2017 Q1
1 quarter
NOW icon
17
ServiceNow
NOW
$143B
$1.45M 1.95%
+68,350
New +$1.34M
2017 Q2
0 quarters
CI icon
18
Cigna
CI
$74.7B
$1.38M 1.85%
8,222
+1,103
+15% +$177K
2016 Q3
3 quarters
UNH icon
19
UnitedHealth
UNH
$339B
$1.38M 1.85%
7,421
-152
-2% -$26.7K
2016 Q2
4 quarters
MDCO
20
DELISTED
Medicines Co
MDCO
$1.36M 1.82%
35,720
-2,983
-8% -$133K
2015 Q2
8 quarters
DXC icon
21
DXC Technology
DXC
$2.04B
$1.32M 1.78%
+19,970
New +$1.33M
2017 Q2
0 quarters
AMZN icon
22
Amazon
AMZN
$2.79T
$1.29M 1.74%
+26,700
New +$1.27M
2017 Q2
0 quarters
MOH icon
23
Molina Healthcare
MOH
$10.9B
$1.27M 1.7%
18,293
+7,144
+64% +$438K
2016 Q2
4 quarters
ABT icon
24
Abbott
ABT
$178B
$1.21M 1.63%
+24,895
New +$1.13M
2017 Q2
0 quarters
V icon
25
Visa
V
$744B
$1.16M 1.56%
12,414
+6,421
+107% +$596K
2017 Q1
1 quarter
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Partner Investment Management held 122 positions worth $74.4M, down 9.4% from $82.1M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Partner Investment Management withdrew a net $18.1M in Q2 2017, closing 36 positions and reducing 27 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 47% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Partner Investment Management opened a new position in McKesson worth $1.63M.

  • Partner Investment Management's largest Q2 2017 buy was McKesson: 9,888 shares worth $1.63M.
  • Partner Investment Management added most to Microsoft in Q2 2017, an estimated $1.31M increase.
  • Partner Investment Management's biggest Q2 2017 reduction was Marvell Technology, cutting an estimated $2.44M.
  • Partner Investment Management fully exited Jazz Pharmaceuticals in Q2 2017, selling an estimated $2.3M.
  • Partner Investment Management's ten largest holdings make up 31% of its $74.4M portfolio in Q2 2017.
  • Partner Investment Management opened 27 new positions and closed 36 in Q2 2017.
  • Partner Investment Management's portfolio value fell 9.4% quarter-over-quarter to $74.4M.

Based on Partner Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.